diclofenac has been researched along with Cancer of Lung in 12 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The intraoperative use of NSAIDs in breast cancer patients (Centre 1) is associated with a reduced recurrence rate (HR = 0." | 1.39 | Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. ( Berliere, M; Canon, JL; Coulie, PG; De Kock, M; Forget, P; Kremer, Y; Legrand, C; Machiels, JP; Poncelet, AJ; Stainier, A; Tombal, B, 2013) |
| "DMBA+Diclofenac group was given daily oral dose of Diclofenac (8 mg/kg of body weight) in addition to DMBA while the last group received Diclofenac only." | 1.36 | Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9, 10 dimethylbenz(a)anthracene (DMBA) and the chemopreventive role of diclofenac. ( Sanyal, SN; Thakur, P, 2010) |
| "The diagnosis of drug-induced pneumonitis was based on a lymphocyte stimulation test that was positive for diclofenac sodium and negative for other drugs." | 1.31 | Diclofenac (Voltaren)-induced pneumonitis after chest operation. ( Fujita, N; Hayashi, M; Sakano, H; Tanaka, T; Ueda, K; Zempo, N, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kothayer, H | 1 |
| Rezq, S | 1 |
| Abdelkhalek, AS | 1 |
| Romero, DG | 1 |
| Elbaramawi, SS | 1 |
| Oliveira, KM | 1 |
| Honorato, J | 1 |
| Gonçalves, GR | 1 |
| Cominetti, MR | 1 |
| Batista, AA | 1 |
| Correa, RS | 1 |
| Forget, P | 1 |
| Machiels, JP | 1 |
| Coulie, PG | 1 |
| Berliere, M | 1 |
| Poncelet, AJ | 1 |
| Tombal, B | 1 |
| Stainier, A | 1 |
| Legrand, C | 1 |
| Canon, JL | 1 |
| Kremer, Y | 1 |
| De Kock, M | 1 |
| Moyer, K | 1 |
| DeWilde, A | 1 |
| Law, C | 1 |
| Cao, Z | 1 |
| Zhou, B | 1 |
| Chen, X | 1 |
| Huang, D | 1 |
| Zhang, X | 1 |
| Wang, Z | 1 |
| Huang, H | 1 |
| Wang, Y | 1 |
| Cao, D | 1 |
| Moody, TW | 1 |
| Switzer, C | 1 |
| Santana-Flores, W | 1 |
| Ridnour, LA | 1 |
| Berna, M | 1 |
| Thill, M | 1 |
| Jensen, RT | 1 |
| Sparatore, A | 1 |
| Del Soldato, P | 1 |
| Yeh, GC | 1 |
| Roberts, DD | 1 |
| Giaccone, G | 1 |
| Wink, DA | 1 |
| Thakur, P | 2 |
| Sanyal, SN | 2 |
| Kato, T | 1 |
| Fujino, H | 1 |
| Oyama, S | 1 |
| Kawashima, T | 1 |
| Murayama, T | 1 |
| Ueda, K | 1 |
| Sakano, H | 1 |
| Tanaka, T | 1 |
| Hayashi, M | 1 |
| Fujita, N | 1 |
| Zempo, N | 1 |
| Hao, JQ | 1 |
| Li, Q | 1 |
| Xu, SP | 1 |
| Shen, YX | 1 |
| Sun, GY | 1 |
| Hodgson, DM | 1 |
| Yirmiya, R | 1 |
| Taylor, AN | 1 |
12 other studies available for diclofenac and Cancer of Lung
| Article | Year |
|---|---|
Triple targeting of mutant EGFR
Topics: Anti-Inflammatory Agents; Celecoxib; Cyclooxygenase 2; Diclofenac; ErbB Receptors; Humans; Lung Neop | 2023 |
Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cattle; Cell Line, Tumor; Coordination Complexes; | 2020 |
Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Carcinoma, Non-Small-Cell | 2013 |
Cystoid macular edema from cancer-associated retinopathy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Therapy, Combination; Fluorescein An | 2014 |
Statil suppresses cancer cell growth and proliferation by the inhibition of tumor marker AKR1B10.
Topics: Acrolein; Aldehyde Reductase; Aldo-Keto Reductases; Antineoplastic Agents; Apoptosis; Biomarkers, Tu | 2014 |
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
Topics: Anethole Trithione; Animals; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proli | 2010 |
Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9, 10 dimethylbenz(a)anthracene (DMBA) and the chemopreventive role of diclofenac.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic | 2010 |
Chemopreventive action of diclofenac in dimethybenzanthracene induced lung cancer in female Wistar rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; Cyclooxygenase 2; Dic | 2010 |
Indomethacin induces cellular morphological change and migration via epithelial-mesenchymal transition in A549 human lung cancer cells: a novel cyclooxygenase-inhibition-independent effect.
Topics: Anticarcinogenic Agents; Aspirin; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Ch | 2011 |
Diclofenac (Voltaren)-induced pneumonitis after chest operation.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Lung Neoplasms; Male; Pneumonecto | 2002 |
Effect of lumiracoxib on proliferation and apoptosis of human nonsmall cell lung cancer cells in vitro.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cycloox | 2008 |
Intracerebroventricular interleukin-1beta impairs clearance of tumor cells from the lungs: role of brain prostaglandins.
Topics: Adenocarcinoma; Animals; Brain; Cyclooxygenase Inhibitors; Diclofenac; Ibuprofen; Injections, Intrav | 2001 |